相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Isolation, characterisation and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn
Prajakta Kulkarni et al.
NATURAL PRODUCT RESEARCH (2021)
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
6. Glycemic Targets: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of Momordica charantia L.
Wilmer H. Perera et al.
MOLECULES (2021)
Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective
Wen Zheng et al.
CLINICAL EPIGENETICS (2021)
Three Selected Edible Crops of the Genus Momordica as Potential Sources of Phytochemicals: Biochemical, Nutritional, and Medicinal Values
Mashudu Muronga et al.
FRONTIERS IN PHARMACOLOGY (2021)
A triterpenoid-enriched extract of bitter melon leaves alleviates hepatic fibrosis by inhibiting inflammatory responses in carbon tetrachloride-treated mice
Mei-Ling Chang et al.
FOOD & FUNCTION (2021)
Saponins of Momordica charantia increase insulin secretion in INS-1 pancreatic β-cells via the PI3K/Akt/FoxO1 signaling pathway
Yufan Liu et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2021)
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
Mohammad Reza Zinatizadeh et al.
GENES & DISEASES (2021)
Polysaccharides from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorate metabolic disorders and gut microbiota change in obese rats
Jia-Jia Wen et al.
FOOD & FUNCTION (2021)
Icariin ameliorates streptozocin-induced diabetic nephropathy through suppressing the TLR4/NF-κB signal pathway
Min-you Qi et al.
FOOD & FUNCTION (2021)
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Nicholas M. Selby et al.
DIABETES OBESITY & METABOLISM (2020)
The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy
Ting-Ting Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
Priscila Calle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
EGCG targeting Notch to attenuate renal fibrosis via inhibition of TGFβ/Smad3 signaling pathway activation in streptozotocin-induced diabetic mice
Qiang-Qiang Zhu et al.
FOOD & FUNCTION (2020)
The protective effect of quercetin on retinal inflammation in mice: the involvement of tumor necrosis factor/nuclear factor-κB signaling pathways
Tin-Yun Ho et al.
FOOD & FUNCTION (2020)
Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The Interconnection Between Immuno-Metabolism, Diabetes, and CKD
Fabrizia Bonacina et al.
CURRENT DIABETES REPORTS (2019)
Risk Factors for Kidney Disease in Type 1 Diabetes
Bruce A. Perkins et al.
DIABETES CARE (2019)
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo J. L. Heerspink et al.
DIABETOLOGIA (2019)
NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis
Guangyan Zhou et al.
NUCLEIC ACIDS RESEARCH (2019)
Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
Massimo Bortolotti et al.
FRONTIERS IN PHARMACOLOGY (2019)
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Keiichiro Matoba et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Momordica charantia in Resisting Obesity
Meiqi Fan et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Polysaccharides from fermented Momordica charantia ameliorate obesity in high-fat induced obese rats
Jia-Jia Wen et al.
FOOD & FUNCTION (2019)
Cordyceps militaris polysaccharides exerted protective effects on diabetic nephropathy in mice via regulation of autophagy
Dan-Dan Chen et al.
FOOD & FUNCTION (2019)
Characterization of Momordica charantia L. polysaccharide and its protective effect on pancreatic cells injury in STZ-induced diabetic mice
Cong Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition
Mohammad Raish et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages
Lynsey D. Jones et al.
PHYTOMEDICINE (2018)
Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway
Hsin-Yi Lo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy
Giacomo Garibotto et al.
JOURNAL OF NEPHROLOGY (2017)
Momordica charantia: a popular health-promoting vegetable with multifunctionality
Shuzhen Wang et al.
FOOD & FUNCTION (2017)
TGF-β: the connecting link between nephropathy and fibrosis
Brijesh Sutariya et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats
Mohammad Raish et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Drug gastrointestinal absorption in rat: Strain and gender differences
Davinia Oltra-Noguera et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
A. Ojima et al.
HORMONE AND METABOLIC RESEARCH (2015)
Inflammatory Cytokines in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF DIABETES RESEARCH (2015)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
DIABETES CARE (2014)
A Novel Insulin Receptor-Binding Protein from Momordica charantia Enhances Glucose Uptake and Glucose Clearance in Vitro and in Vivo through Triggering Insulin Receptor Signaling Pathway
Hsin-Yi Lo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
Optimization of Evans blue quantitation in limited rat tissue samples
Hwai-Lee Wang et al.
SCIENTIFIC REPORTS (2014)
Approaches for enhancing oral bioavailability of peptides and proteins
Jwala Renukuntla et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Momordica charantia and Its Novel Polypeptide Regulate Glucose Homeostasis in Mice via Binding to Insulin Receptor
Hsin-Yi Lo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
DNA microarray analysis as a tool to investigate the therapeutic mechanisms and drug development of Chinese medicinal herbs
Chia-Cheng Li et al.
BIOMEDICINE-TAIWAN (2012)
Mouse models of diabetic nephropathy
Charles E. Alpers et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Pathophysiology of the Diabetic Kidney
Volker Vallon et al.
COMPREHENSIVE PHYSIOLOGY (2011)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats
G. Suresh Kumar et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy
ZH Qi et al.
DIABETES (2005)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
